Dyslipidemia: Clinical Trials

145 trials for Dyslipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

88 completed, 17 recruiting, 15 not yet recruiting, 14 unknown. 145 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable145Completed 88, Recruiting 17, Not yet recruiting 15, Unknown 14, Active not recruiting 4, Terminated 3, Enrolling by invitation 2, Suspended 1, Withdrawn 1

Follow Dyslipidemia: new trials by email Literature Review of Dyslipidemia trials Research Report on Dyslipidemia

Trials (filtered) newest first · largest first

All 145 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient-engaged Development and Testing of Educational Content on Side Effects of Statins
Educational content on statin side effects - Dyslipidemia
Not applicableSuspendedWeill Medical College of Cornell University302028-09-012026-09-23
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Multimodal AI-Driven Out-of-Hospital Management for Hypertension and Cardiometabolic Risk
Hybrid AI-Enabled Out-of-Hospital Health Management, Standard Out-of-Hospital Guidance - Hypertension, Hyperglycemia
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases1502026-11-032026-11-04
Community Physical Exercise Program in Chronic Disease
Physical Exercise - Osteoarthritis Pain, Myocardial Infarction (MI)
Not applicableNot yet recruitingAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv1502026-10-012026-09-10
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
Pharmacist-led lipid optimization pathway - ACS (Acute Coronary Syndrome), Hyperlipidemia
Not applicableRecruitingUniversity of Alberta20002026-08-102026-09-09
Effect of macaúba Oil Combined With Green Exercises
Macauba oil, Placebo, Daytime Green Exercise - Stress Mental, Dyslipidemia
Not applicableNot yet recruitingFederal University of Minas Gerais602026-08-012026-07-20
Polypills Approach for Multiple Cardiovascular Risk Factors
Fixed-Dose Combination Strategy - Hypertension, Dyslipidemia
Not applicableRecruitingChina Medical University, China82522026-07-112026-09-16
Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids
Policosanol, Placebo, Concurrent Exercise Training - Dyslipidemia, Elevated Blood Lipids
Not applicableNot yet recruitingMahidol University1202026-06-222026-07-17
Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
Kodo Millet Porridge Beverage - Obesity & Overweight, Metabolic Syndrome
Not applicableRecruitingJSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH502026-06-012026-07-14
Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth
Nutrition education and produce prescription card - Dyslipidemia, Hypertension
Not applicableNot yet recruitingBoston Children's Hospital1502026-06-012026-04-22
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Moderate-intensity statin and ezetimibe combination therapy, High-intensity statin monotherapy - Renal Insufficiency, Atherosclerosis
Not applicableRecruitingYonsei University19522026-05-282026-06-16
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
LLM-Enabled Co-management - Hypertension, Diabetes
Not applicableActive not recruitingFirst Hospital of China Medical University68002026-05-142026-09-04
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
Digital Care Community Common Good Program, Usual Care - Type2Diabetes, Hypertension
Not applicableRecruitingChang Gung University of Science and Technology1692026-05-122026-08-21
Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals
Cardiol Forte, Placebo - Dyslipidemia
Not applicableNot yet recruitingU.G.A. Nutraceuticals502026-05-042026-04-20
Supplementation With Salicornia Extract Rich in Polyphenols (B-Salicornia) to Improve Vascular Health in Patients With Dyslipidemia Who Are Not Candidates for Drug Treatment (Low to Moderate Risk)
Halophyte plant extracts - Dyslipidemia
Not applicableNot yet recruitingFundación Pública Andaluza para la gestión de la Investigación en Sevilla2502026-05-012026-04-30
Implementation Facilitation of Exercise is Medicine Greenville
Clinic Implementation Facilitation - Physical Inactivity, Dyslipidemia
Not applicableNot yet recruitingUniversity of South Carolina352026-05-012026-04-02
To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years
PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program - Cardiometabolic Conditions, Hypertension (HTN)
Not applicableEnrolling by invitationUniversity of Hawaii4002026-05-012026-06-09
Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals
Low-Calorie Diet Rich in Medium-Chain Triglycerides (MCTs) Based on Traditional Minangkabau Foods - Metabolically Unhealty Obese, Dyslipidemia
Not applicableNot yet recruitingAndalas University402026-04-012026-04-13
A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Experimental - 12 Week P3-EX Unsupervised Exercise Program with Virtual Weekly Oversight from Graduate Research Assistants, Active Control - 12 Week ACSM-PAVS Unsupervised Exercise Program with Virtual Weekly Oversight from Graduate Research Assistants - Hypertension, Dyslipidemia
Not applicableRecruitingUniversity of Connecticut722026-03-302026-10-16
The Effects of Rosuvastatin on Running Training Adaptation and Safety
Rosuvastatin - Dyslipidemia, Long-Distance Running
Not applicableNot yet recruitingTaipei Medical University WanFang Hospital402026-03-012026-02-10

Showing 20 of 145. Sign in to see all of them.

Narrower conditions

Dyslipidemias (145)  ·  Hypertension (51)  ·  Obesity (44)  ·  Diabetes Mellitus (35)  ·  Metabolic Syndrome (23)  ·  Overweight (22)  ·  Cardiovascular Diseases (19)  ·  Insulin Resistance (17)  ·  Diabetes Mellitus, Type 2 (13)  ·  Inflammation (12)  ·  Motor Activity (7)  ·  Glucose Intolerance (6)  ·  Hyperglycemia (6)  ·  Hypercholesterolemia (5)  ·  Hyperlipidemias (5)

Broader conditions

Lipid Metabolism Disorders (145)  ·  Metabolic Diseases (145)  ·  Nutritional and Metabolic Diseases (145)  ·  Glucose Metabolism Disorders (72)  ·  Pathological Conditions, Signs and Symptoms (72)  ·  Signs and Symptoms (60)  ·  Body Weight (55)  ·  Vascular Diseases (55)  ·  Nutrition Disorders (54)  ·  Overnutrition (54)  ·  Endocrine System Diseases (49)  ·  Cardiovascular Diseases (48)  ·  Overweight (32)  ·  Hyperinsulinism (31)  ·  Pathologic Processes (20)

Interventions

Diet (7)  ·  Exercise (7)  ·  Control Groups (3)  ·  Diet, Fat-Restricted (3)  ·  Fructose (3)  ·  Diet Therapy (2)  ·  Dietary Supplements (2)  ·  Glucose (2)  ·  Haloperidol (2)  ·  Milk (2)  ·  Niacin (2)  ·  Oleic Acid (2)  ·  Palmitic Acid (2)  ·  Simvastatin (2)  ·  Sugars (2)

Sponsors

UCSF Benioff Children's Hospital Oakland (8)  ·  Tufts University (5)  ·  University of California, Davis (4)  ·  Maastricht University Medical Center (3)  ·  Universidade Federal do Rio de Janeiro (3)  ·  University of Georgia (3)  ·  University of Hawaii (3)  ·  Boston Children's Hospital (2)  ·  Gateway Health Alliance (2)  ·  Hospital de Clinicas de Porto Alegre (2)  ·  Leiden University Medical Center (2)  ·  Mexican National Institute of Public Health (2)  ·  University of Alberta (2)  ·  University of Toronto (2)  ·  Aarhus University Hospital (1)

Countries

United States (52)  ·  Canada (9)  ·  China (8)  ·  Netherlands (6)  ·  Brazil (5)  ·  Denmark (4)  ·  Italy (4)  ·  South Korea (4)  ·  Taiwan (4)  ·  Mexico (3)  ·  Argentina (2)  ·  Cameroon (2)  ·  Germany (2)  ·  Hong Kong (2)  ·  Indonesia (2)

Top investigators

Ronald M Krauss, MD (6)  ·  Ronald P Mensink, PhD (3)  ·  Alice H Lichtenstein, D.Sc. (2)  ·  Jamie Cooper, PhD (2)  ·  Joseph K Kaholokula, PhD (2)  ·  Kimber L Stanhope, Ph.D, R.D. (2)  ·  Nia Aitaoto, PhD (2)  ·  Ronald M Krauss, M.D. (2)  ·  Adolfo Rubinstein, MD, MSc, PhD (1)  ·  Alejandra Farias-Godoy, MD, MSc (1)  ·  Alice H. Lichtenstein, D.Sc. (1)  ·  Allan Vaag, PhD, DMsc (1)  ·  Ana Palacio (1)  ·  Ana Velikonja, PhD student (1)

Results publications

PMID 16779380, PMID 17238648, PMID 17238690, PMID 17644623, PMID 18375417, PMID 18567058, PMID 18606913, PMID 18687759, PMID 18999065, PMID 19047532, PMID 19171813, PMID 19254366, PMID 19614793, PMID 19828712, PMID 19841042, PMID 19966072, PMID 20216298, PMID 20332353, PMID 20386337, PMID 20422396, PMID 20484485, PMID 20495438, PMID 20682679, PMID 20876408, PMID 21512162, PMID 21545273, PMID 21593294, PMID 21613559, PMID 21730080, PMID 21836103, PMID 21956423, PMID 21959345, PMID 22064686, PMID 22264468, PMID 22334468, PMID 22354851, PMID 22455415, PMID 22513296, PMID 22623392, PMID 22961907, PMID 23012688, PMID 23143672, PMID 23223405, PMID 23288372, PMID 23359362, PMID 23410564, PMID 23446895, PMID 23663789, PMID 23757437, PMID 23796131

NIH funding

OT2HL158287 (2), 2025 (1), K23HL085308 (1), P20RR016464 (1), P50MD017338 (1), R01HL070790 (1), R01HL075675 (1), R01HL091333 (1), R01HL106003 (1), R01HL107256 (1), R01HL117939 (1), R44HL082382 (1), U01DK056990 (1), U01DK056992 (1), U01DK057002 (1)